Novel human kinase and polynucleotides encoding the same

• US 20050053982A1
• Filed: 06/21/2004
• Published: 03/10/2005
• Est. Priority Date: 06/13/2001
• Status: Abandoned Application

• Current Assignee: Carl Johan Friddle, Nathaniel L. Wilganowski, Walke D. Wade, Yi Hu
• Original Assignee: Carl Johan Friddle, Nathaniel L. Wilganowski, Walke D. Wade, Yi Hu
• Inventors: Hu, Yi, Wilganowski, Nathaniel L., Walke, D. Wade, Friddle, Carl Johan
• Application Number:
  US10/872,762
• Publication Number:
  US 20050053982A1
• Time in Patent Office: Days
• US Class Current: 435/6
• CPC Class Codes: C07H 21/04 with deoxyribosyl as saccharide radical
• CPC Class Codes: C12N 9/12 transferring phosphorus containing groups, e.g. kinases (2.7)

Abstract

Novel human polynucleotide and polypeptide sequences are disclosed that can be used in therapeutic, diagnostic, and pharmacogenomic applications.

Claims

1-12. -12. (cancelled)

13. A substantially isolated polypeptide having the amino acid sequence of SEQ ID NO:

2.

14. A substantially isolated antibody having immunospecificity for the polypeptide sequence of SEQ ID NO:

2.

15. A method of expressing the amino acid sequence of SEQ ID NO:

2 in a cell, comprising

providing an expression vector encoding amino acid sequence of SEQ ID NO;

2;

introducing the vector into a cell, and

maintaining the cell under conditions permitting expression of the amino acid sequence of SEQ ID NO;

2 by the cell.